Balyasny Asset Management

Balyasny Asset Management’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Balyasny Asset Management’s Portfolio LHDX Stock Details LHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell
2022 Q4	$30.1K	Sell
2022 Q3	$346K	Hold
2022 Q2	$607K	Buy
2021 Q4	–	Sell
2021 Q3	$710K	Buy
2021 Q2	$240K	Sell
2021 Q1	$1.22M	Buy